EUVIMEDEUVIMED entdecken
Crossref

Ambroxol mitigates renal ischemia/reperfusion-induced cardiac and renal injury via Nrf2/HO-1 activation and TLR4 pathway inhibition

Hadeer A Fayed, Somaia A Abdel-Sattar, Azza S Awad iD

Journal of Pharmacy and Pharmacology · 2025

DOI: 10.1093/jpp/rgaf064 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2025. Verfasst von Hadeer A Fayed und 2 weiteren Autor:innen. Beteiligte Einrichtung: Egyptian Drug Authority, 51 Wizaret el Zeraa St. Al Agouzah, Cairo 12611, Egypt. Hauptthemen laut MEDLINE: Toll-Like Receptor 4, NF-E2-Related Factor 2, Ambroxol, Reperfusion Injury. Die Arbeit nennt 56 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ambroxol is a mucokinetic drug with antioxidant and anti-inflammatory properties. Renal ischemia/reperfusion (IR) is the cause of acute kidney injury that usually occurs with other comorbidities.

Objectives

To explore ambroxol for repurposing against renal IR-induced cardio-renal injury.

Methods

Sprague–Dawley rats were assigned into: Sham group (Group I), untreated renal IR group (Group II), and ambroxol-pretreated group (Group III). Cardiac injury parameters, histopathology, and oxidative and antioxidant status, plus signaling molecules related to hypoxia, inflammation, mitochondrial dysfunction, and apoptosis were evaluated. Key findings Ambroxol administration significantly (P < .001) improved the IR-deteriorated cardiac biomarkers and histopathology and up-regulated the Nrf2/HO-1 pathway to increase antioxidant capacity. The cardio-renal expression of hypoxia-inducible factor (HIF)-1α was significantly (P < .001) attenuated by ambroxol. Ambroxol also attenuated inflammation by significant (P < .001) down-regulation of TLR4, p38 mitogen-activated protein kinase, nuclear factor kappa B, and nod-like receptor protein 3 expression while decreasing IL-1β and TNF-α secretion. Moreover, ambroxol significantly (P < .001) ameliorated mitochondrial dysfunction and apoptosis. Statistical results revealed positive correlations between the expression of TLR4 and HIF-1 and between TLR4 and dynamin-related protein 1.

Conclusions

Ambroxol’s cardio-renal protecting potential was elicited by inhibiting oxidative stress, inflammation, and mitochondrial dysfunction through activating the Nrf2/HO-1 pathway and inhibiting multiple TLR4-interconnected signaling pathways, thus affording a theoretical base for ambroxol’s clinical use in renal IR-induced injuries.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Toll-Like Receptor 4NF-E2-Related Factor 2AmbroxolReperfusion InjuryAcute Kidney InjuryAnimalsRats, Sprague-DawleyMaleRatsSignal TransductionKidneyAntioxidantsOxidative StressHeme Oxygenase (Decyclizing)ApoptosisAnti-Inflammatory AgentsHypoxia-Inducible Factor 1, alpha SubunitDisease Models, Animal

Stichwörter der Autor:innen

Nrf2/HO-1 pathwayTLR4 pathwayambroxolinflammationmitochondrial dysfunctionrenal ischemia

Substanzen

Toll-Like Receptor 4NF-E2-Related Factor 2AmbroxolTlr4 protein, ratNfe2l2 protein, ratHmox1 protein, ratAntioxidantsHeme Oxygenase (Decyclizing)Anti-Inflammatory AgentsHypoxia-Inducible Factor 1, alpha Subunit

Autor:innen und Institutionen

  • Egyptian Drug Authority, 51 Wizaret el Zeraa St. Al Agouzah, Cairo 12611, Egypt.
  • Department of Pharmacology & Toxicology, Faculty of Pharmacy (Girls), Al-Azhar University, Nasr City, Cairo 11651, Egypt.

ORCID-Profile: Azza S Awad

Zitieren

APA

Fayed, H. A., Abdel-Sattar, S. A., & Awad, A. S. (2025). Ambroxol mitigates renal ischemia/reperfusion-induced cardiac and renal injury via Nrf2/HO-1 activation and TLR4 pathway inhibition. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgaf064

Vancouver

Fayed HA, Abdel-Sattar SA, Awad AS. Ambroxol mitigates renal ischemia/reperfusion-induced cardiac and renal injury via Nrf2/HO-1 activation and TLR4 pathway inhibition. Journal of Pharmacy and Pharmacology. 2025. doi:10.1093/jpp/rgaf064

BibTeX
@article{Fayed2025,
  author = {Fayed, Hadeer A and Abdel-Sattar, Somaia A and Awad, Azza S},
  title = {Ambroxol mitigates renal ischemia/reperfusion-induced cardiac and renal injury via Nrf2/HO-1 activation and TLR4 pathway inhibition},
  journal = {Journal of Pharmacy and Pharmacology},
  year = {2025},
  doi = {10.1093/jpp/rgaf064}
}
Kostenlos starten →